Literature DB >> 11161976

Characterization of high-risk HIV-1 seronegative hemophiliacs.

J R Salkowitz1, S F Purvis, H Meyerson, P Zimmerman, T R O'Brien, L Aledort, M E Eyster, M Hilgartner, C Kessler, B A Konkle, G C White, J J Goedert, M M Lederman.   

Abstract

Mechanisms that protect most high-risk HIV-1 seronegative (HRSN) persons are not well understood. Among hemophiliacs from the Multicenter Hemophilia Cohort Study who remained HIV-1 seronegative despite a high (94%) risk for acquisition of HIV-1 infection, only 7/43 were homozygous for the protective CCR5 Delta32 polymorphism. Among the remainder, neither CCR5 density nor beta-chemokine production, nor in vitro susceptibility to infection with the HIV-1 isolate JR-FL could distinguish HRSN hemophiliacs from healthy controls. When compared to lymphocytes of healthy controls not at risk for HIV-1 infection, diminished spontaneous lymphocyte proliferation was seen in lymphocytes of HRSN hemophiliacs as well as in lymphocytes of hemophiliacs not at risk for HIV-1 infection. Surprisingly sera/plasmas obtained from high-risk HIV-1 seropositve hemophiliacs prior to seroconversion more often contained alloreactive antibodies than date-matched sera/plasmas obtained from HRSN hemophiliacs. Thus alloreactivity may predispose to acquisition of HIV-1 infection after parenteral exposure. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11161976     DOI: 10.1006/clim.2000.4969

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  29 in total

1.  Outcomes of a National Institute of Allergy and Infectious Diseases Workshop on understanding HIV-exposed but seronegative individuals.

Authors:  Janet M Young; Jim A Turpin; Runa Musib; Opendra K Sharma
Journal:  AIDS Res Hum Retroviruses       Date:  2011-01-15       Impact factor: 2.205

2.  CCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitro.

Authors:  Janelle R Salkowitz; Shannon E Bruse; Howard Meyerson; Hernan Valdez; Donald E Mosier; Clifford V Harding; Peter A Zimmerman; Michael M Lederman
Journal:  Clin Immunol       Date:  2003-09       Impact factor: 3.969

3.  Human immunodeficiency virus fusion to dendritic cells declines as cells mature.

Authors:  Marielle Cavrois; Jason Neidleman; Jason F Kreisberg; David Fenard; Christian Callebaut; Warner C Greene
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Testing for risk and protective trends in genetic analyses of HIV acquisition.

Authors:  Janice M Mccarthy; Patrick R Shea; David B Goldstein; Andrew S Allen
Journal:  Biostatistics       Date:  2014-09-29       Impact factor: 5.899

5.  Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers.

Authors:  Asier Sáez-Cirión; Chiraz Hamimi; Anna Bergamaschi; Annie David; Pierre Versmisse; Adeline Mélard; Faroudy Boufassa; Françoise Barré-Sinoussi; Olivier Lambotte; Christine Rouzioux; Gianfranco Pancino
Journal:  Blood       Date:  2011-06-03       Impact factor: 22.113

Review 6.  Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN).

Authors:  C Tomescu; S Abdulhaqq; L J Montaner
Journal:  Clin Exp Immunol       Date:  2011-03-17       Impact factor: 4.330

Review 7.  Determinants of protection among HIV‐exposed seronegative persons: an overview.

Authors:  Michael M Lederman; Galit Alter; Demetre C Daskalakis; Benigno Rodriguez; Scott F Sieg; Gareth Hardy; Michael Cho; Donald Anthony; Clifford Harding; Aaron Weinberg; Robert H Silverman; Daniel C Douek; Leonid Margolis; David B Goldstein; Mary Carrington; James J Goedert
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

8.  Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individuals.

Authors:  Wildeman Zapata; Benigno Rodriguez; Jan Weber; Hernando Estrada; Miguel E Quiñones-Mateu; Peter A Zimermman; Michael M Lederman; Maria T Rugeles
Journal:  Curr HIV Res       Date:  2008-11       Impact factor: 1.581

9.  A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A.

Authors:  Jérôme Lane; Paul J McLaren; Lucy Dorrell; Kevin V Shianna; Amanda Stemke; Kimberly Pelak; Stephen Moore; Johannes Oldenburg; Maria Teresa Alvarez-Roman; Anne Angelillo-Scherrer; Francoise Boehlen; Paula H B Bolton-Maggs; Brigit Brand; Deborah Brown; Elaine Chiang; Ana Rosa Cid-Haro; Bonaventura Clotet; Peter Collins; Sara Colombo; Judith Dalmau; Patrick Fogarty; Paul Giangrande; Alessandro Gringeri; Rathi Iyer; Olga Katsarou; Christine Kempton; Philip Kuriakose; Judith Lin; Mike Makris; Marilyn Manco-Johnson; Dimitrios A Tsakiris; Javier Martinez-Picado; Evelien Mauser-Bunschoten; Anne Neff; Shinichi Oka; Lara Oyesiku; Rafael Parra; Kristiina Peter-Salonen; Jerry Powell; Michael Recht; Amy Shapiro; Kimo Stine; Katherine Talks; Amalio Telenti; Jonathan Wilde; Thynn Thynn Yee; Steven M Wolinsky; Jeremy Martinson; Shehnaz K Hussain; Jay H Bream; Lisa P Jacobson; Mary Carrington; James J Goedert; Barton F Haynes; Andrew J McMichael; David B Goldstein; Jacques Fellay
Journal:  Hum Mol Genet       Date:  2013-01-30       Impact factor: 6.150

10.  PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes.

Authors:  Tatsuyoshi Kawamura; Shannon E Bruse; Awet Abraha; Makoto Sugaya; Oliver Hartley; Robin E Offord; Eric J Arts; Peter A Zimmerman; Andrew Blauvelt; Shannon E Bruce
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.